Dr. Sainath Bhethanabhotla

Consultant Medical Oncologist & Paediatric Hemato – Oncologist Care Hospitals, Hyderabad

Email: drsainath@kaizenoncology.com

Phone Number: 9154143858

Dr. Sainath Bhethanabhotla
Consultant Medical Oncologist & Paediatric Hemato – Oncologist Care Hospitals, Hyderabad

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Get an Appointment
  • Monday - Friday 9:00 AM – 5:30 PM

  • Old Mumbai Hwy, near Cyberabad Police Commissionerate, Jayabheri Pine Valley, HITEC City, Hyderabad, Telangana 500032

My Qualifications

  • MBBS, Osmania Medical College, Hyderabad
  • MD, Paediatrics - All India Institute of Medical Sciences
  • DM - Medical Oncology , Dr. BR Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences


  • Resident Super Specialist, MNJ Institute of Oncology & Regional Cancer Centre, ,Hyderabad
  • Senior Resident, Department of Medical Oncology - All India Institute of Medical Sciences,New Delhi
  • Consultant, Medical Oncologist - Krishna Institute of Medical Sciences ,Hyderabad
  • Consultant , Soumya Multispecialty Hospital,Hyderabad

<h3>Research Presentation</h3><ul><li>Outcome of pediatric Hodgkin lymphoma patients treated with ABVD in a tertiary care center in India. [DM- Thesis]</li><li>Prognostic significance of IL-6 expression by immunohistochemistry in pediatric Hodgkin lymphoma treated with ABVD chemotherapy. [MD-Thesis]</li><li>Role of Change of Position during Phototherapy in Management of Non-Haemolytic Hyperbilirubinemia in Late Preterm and Term Infants-Randomized Controlled Trial</li></ul><h3>Publications</h3><ul><li>Bhethanabhotla S, Bakhshi S. Reply: Neither Post-Treatment PET-CT Nor Interim PET-CT Using Deauville Criteria Predicts Outcome In Pediatric Hodgkin Lymphoma. J Nucl Med. 2016 Dec8; IMPACT FACTOR: 7.439</li><li>Bhethanabhotla S, Jain S, Kapoor G, Mahajan A, Chopra A, Vishnubhatla S, Et Al. Outcome Of Pediatric Advanced Hodgkin Lymphoma Treated With ABVD And Predictors Of Inferior Survival: A Multicenter Study Of 186 Patients. Leuk Lymphoma. 2016 Dec 6;1–7. IMPACT FACTOR:2.644</li><li>Bakhshi S, Bhethanabhotla S, Kumar R, Agarwal K, Sharma P, Thulkar S, Et Al. Post-Treatment PET-CT Rather Than Interim PET-CT Using Deauville Criteria Predicts Outcome In Pediatric Hodgkin Lymphoma: A Prospective Study Comparing PET-CT Versus Conventional Imaging. J Nucl Med. 2016 Oct 6; IMPACT FACTOR: 7.439</li><li>Bhethanabhotla S, Bakhshi S. Presence Of Risk Factors Does Not Affect Outcome In Early Stage Pediatric Hodgkin Lymphoma Treated With ABVD. Ann Hematol. 2016 Nov 18; IMPACT FACTOR: 2.845</li><li>Taywade SK, Kumar R, Bhethanabhotla S, Bal C. Role Of (18)F-FDG PET-CT In Monitoring The Cyclophosphamide Induced Pulmonary Toxicity In Patients With Breast Cancer - 2 Case Reports. Nucl Med Mol Imaging. 2016 Sep;50(3):261–5.</li><li>Kakkar A, Rajeshwari M, Bhethanabhotla S, Kaur K, Jain D, Gogia A, Et Al. Primary Diffuse Large B-Cell Lymphoma Of The Prostate: A Report Of Two Cases With Diagnostic Considerations. J Cancer Res Ther. 2015 Dec;11(4):977–9. IMPACT FACTOR: 0.8459</li><li>Gajendra S, Gogia A, Tanwar P, Sahoo MK, Bhethanabhotla S, Durgapal P, Et Al. Synchronous Metastatic Pulmonary Adenocarcinoma With Small Cell Lymphoma. Leuk Lymphoma. 2014 Jul;55(7):1678–80. IMPACT FACTOR: 2.644</li><li>Bhethanabhotla S, Thukral A, Sankar MJ, Agarwal R, Paul VK, Deorari AK. Effect Of Position Of Infant During Phototherapy In Management Of Hyperbilirubinemia In Late Preterm And Term Neonates: A Randomized Controlled Trial. J Perinatol. 2013 Oct;33(10):795–9. IMPACT FACTOR: 2.183</li><li>Kumar L, Boya RR, Pai R, Harish P, Mookerjee A, Sainath B, Et Al. Autologous Stem Cell Transplantation For Multiple Myeloma: Long-Term Results. The National Medical Journal Of India. 2016 Jul 1;29(4):192. IMPACT FACTOR: 0.786</li><li>Bhethanabhotla, S., Tiwari, A., Sharma, M.C. Et Al. Prognostic Significance Of IL-6 In Hodgkin Lymphoma. Indian J Pediatr. 2019 Mar 4; Online First. IMPACT FACTOR: 1.046</li><li>Patel A, Tannock I, Bhethanabhola S, Srivastva P, Biswas B, Et Al. Low-Dose Abiraterone In Metastatic Prostate Cancer: Is It Practice Changing? Facts And Facets.JCO Glob Oncol. 2020 Mar;6:382-386. IMPACT FACTOR:1.79</li></ul><h3>Award and Recognition</h3><ul><li>Won Sorel Catherine Prize For Best Post Graduate in Pediatrics For The Year 2012.</li><li>Stood 2nd in NNF Gold Medal Paper For The Year 2012(1).</li><li>Received Scholarship For Oral Presentation in SIOP-2015, Cape Town, South Africa For The Abstract “OUTCOME OF PEDIATRIC HODGKIN LYMPHOMA TREATED WITH ABVD: A MULTICENTRIC ANALYSIS OF 335 PATIENTS”.</li><li>Awarded “Abstract Achievement Award” at American Society of Hematology Meeting on Hematological Malignancies Held in Chicago on 16th,17th September 2016 For The Abstract “Prognostic Significance of Neutrophil-Lymphocyte Ratio in Advanced Pediatric Hodgkin Lymphoma-A Multicentric Analysis of 186 Patients”</li></ul><p><br></p>

Patient Testimonials

Dr. Sainath Bhethanabhotla is a great doctor! He’s very understanding and listens to your concerns. He takes time with the patient to help them with their health issues and informs the best treat options available to us! My father is treated by him and his suggested Chemotherapy is very responsive with the medicines he recommended and I highly recommend him to anyone looking for a Medical Oncology specialist. Further, his staff also very friendly and helpful..

We have a wonderful experience with CARE Hospital. Here Doctors and their supporting staff are so cooperative and we never had an issue with either of them. I especially respect, how Dr. Sainath Bethanabhotla sir really took his time to explain the problem as well as the treatment options, which have really put me at ease. I have been part of his treatment for more than two years (since 2020). He is very professional, responsible, knowledgeable and super caring. He relates well to patients as well as their family members and taking time to listen issues carefully and take appropriate action on the symptoms after correct diagnosis. I strongly believe that he is more than just a Doctor. So I confidently recommend that Dr Sainath sir as a good reference for needed people. Thank you Dr Sainath sir, tq so much for your kind concern and great support.

Dr Sainath has been very supportive all through the treatment and has been patient enough to answer all our queries. He has ensured that the this treatment period becomes easier, comfortable and showing the right path to recovery. Our sincere thanks to Dr Sainath and all his team members.

Dr. Sainath is the very best we have in the city. We've been going to him for nearly a year now and every time we visit him there's a sense of calm with which he addresses everything. Thank you so much sir. And under your guidance we'll surely fight this out. Thank you Sir🙏

Dr sainath sir is simply super and straight forward person who always care about the patient .

Get a Second Opinion

Make your right decision... Your Health Matters

Get in touch


Here are some informative blog articles for the education purpose of our patients, prospective patients, website visitors.

Regular News

Get to know the information regarding our healthcare aspects to be able to get to better informed decisions. ..

Get ready

Our Newsletter

Copyright © 2022 kaizen rights reserved.